Lupus

Article	Citations
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	36
Predictors for early readmission in patients hospitalized with new onset pediatric lupus nephritis	35
The challenges in diagnosing pediatric primary antiphospholipid syndrome	28
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	27
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	26
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	24
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	22
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	22
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	20
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	20
Long COVID in patients with systemic lupus erythematosus: A case-control study	20
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	20
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	19
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	18
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	18
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	18
New-onset lupus nephritis associated with COVID-19 infection	17
Low disease activity state in juvenile-onset systemic lupus erythematosus	16
Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at SLE diagnosis, and disease duration-c	16
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	15
Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States	15
Naomi Rothfield, MD, MACR 1929-2023	15
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	15
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus	15
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	15

A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	15
Considering belimumab during pregnancy: A more viable option over time	15
Thanks to Reviewers	14
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	14
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	14
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	14
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	14
Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients	13
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study	13
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	13
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	13
Obinutuzumab in patients with repeated lupus nephritis flares: A case series	12
Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	12
Reversible dilated cardiomyopathy in systemic lupus erythematosus: A case report	12
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	12
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	12
Cardiac magnetic resonance feature tracking evaluates left atrial strain in patients with systemic lupus erythematosus and mitral regurgitation	12
Systemic lupus erythematosus with diffuse intracranial calcification: A case report and review of literature	11
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	11
Relationship between serum lipopolysaccharide binding protein levels, disease activity, and clinical characteristics in Paraguayan patients with systemic lupus erythematosus	11
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort	11
Induction treatment for lupus nephritis at a high-complexity hospital in Chile	11
Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis	11
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus	11
Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting FOXP3 transcription: A new potential biomarker in systemic lupus erythematosus	10
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors	10
Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India	10
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses	10
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis	10
Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China	10
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States	10
Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome	10
Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients	10
Steroid-free flare management of a severe cutaneous lupus flare with anifrolumab	10
Comparison of hydroxychloroquine titers measured in frozen/thawed serum and whole blood obtained from lupus patients	10
The (reverse) paradox of lupus anticoagulant: A case report	10
The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus	10
Early onset left ventricular remodeling in juvenile systemic lupus erythematosus; Insight from 3-dimensional speckle tracking echocardiography	10
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients	9
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort	9
Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience	9
Summary of the 12th Meeting of the European Forum on antiphospholipid antibodies ONLINE	9
Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review	9
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus	9
Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus	9
“Long COVID in patients with systemic lupus erythematosus: A case‒control study”—a methodological consideration	9
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus	9
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS)	9
Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index	9
Factors mediating cancer risk in systemic lupus erythematosus	9

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey	9
Association between cognitive impairment and olfactory deficits in systemic lupus erythematosus without major neuropsychiatric syndromes	9
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study	9
T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE	8
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients	8
Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study	8
Research progress in functional magnetic resonance imaging assessment of lupus nephritis kidney injury	8
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review	8
Long-term outcome and predictors of long-term outcome in patients with lupus nephritis managed at a tertiary hospital in Mumbai	8
Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness	8
A novel long noncoding RNA ENST00000597482 serves as a potential biomarker for disease activity and diagnosis of systemic lupus erythematosus	8
A 5–year follow-up of pulmonary function tests in childhood-onset systemic lupus erythematosus: a single-center retrospective study	8
Proportion, domains, and risk factors of cognitive impairment in systemic lupus erythematosus	8
Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus	8
Epidemiology of disease-activity related ophthalmological manifestations in Systemic Lupus Erythematosus: A systematic review	8
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register	8
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	8
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study	8
Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous	8
Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	7
Cytomegalovirus infection and disease in systemic lupus erythematosus patients at a high-complexity hospital in southwestern Colombia	7
Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review	7
Oral lesions of systemic lupus erythematosus: A collaborative Latin American study	7
The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance	7
Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations	7
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study	7
Correspondence on “relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus” by Chi Chiu Mok et al	7
Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII	7
A single-center model for implementation of SLEDAI documentation adherence in childhood-onset systemic lupus erythematosus (cSLE)	7
Healthcare costs of systemic lupus erythematosus in New Zealand	7
Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus	7
Predictive model of risk and severity of enteritis in systemic lupus erythematosus	7
Systemic lupus erythematosus-related acute lung disease	7
Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis	7
Bacteremia in systemic lupus erythematosus: Risk factors, clinical and microbiological characteristics, and outcomes in the largest single-center retrospective cohort in Japan	7
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics	7
Premature ovarian failure in juvenile systemic lupus erythematosus patient: A rare presentation	7
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	7
Drug-induced lupus erythematosus in childhood: Case-based review	7
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study	7
Determinants of sexual function in male patients with systemic lupus erythematosus	7
Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus	7
Regarding the efficacy of the COVID-19 vaccine in pediatric systemic lupus erythematosus patient	7
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy	7
Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus	7
Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study	7
A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus	7
MBL2 gene polymorphisms and its relation to infection in Brazilian systemic lupus erythematosus patients: A 10-years follow-up study	7
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis	7
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis	7
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	6
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus	6
Parkinsonism as the presenting manifestation of lupus: A case-based review	6
Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature	6
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	6
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	6
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications	6
Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry	6
Efficacy and safety of telitacicept in the treatment of systemic lupus erythematosus: A retrospective real-world study	6
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study	6
Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population	6
What you need to know about migraine in Hughes syndrome patients	6
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	6
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects	6
Treatment adherence and quality of life in colombian patients with lupus nephritis	6
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	6
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	6
Literature review of lupus nephritis From the Arabian Gulf region	6
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	6
Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic	6
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch	6
Severe gastrointestinal manifestations in childhood-onset lupus: A single-center cohort and review of the literature	6
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	6
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	6
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	6
Are autoimmune diseases autoinflammatory: Is it time to change the paradigm?	6
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study	6
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	6
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	6
Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus	6

Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	6
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	6
Alterations of spontaneous brain activity in systematic lupus erythematosus patients without neuropsychiatric symptoms: A resting-functional MRI study	6
Early diagnosis of lupus: A possibilty. A multicentric study from SLE Special Interest Group (SIG) of Indian Rheumatology Association (IRA)	6
Corrigendum to The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	6
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	6
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study	6
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	6
Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population	5
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus	5
Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus	5
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review	5
Renal function deterioration is an independent mortality determinant in Koreans diagnosed with lupus nephritis	5
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	5
Comparative efficacy of intravenous cyclophosphamide, mycophenolate mofetil, and tacrolimus as induction therapy for lupus nephritis: A randomized controlled open-label trial	5
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis	5
Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019	5
Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients	5
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series	5
Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases	5
Health-Related Quality of Life and fatigue are associated with a higher work productivity impairment in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	5
Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus	5
Diving deep into lupus: Gastrointestinal involvement insights from the Oman lupus study	5
Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus	5
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam	5
Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis	5
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	5
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	5
Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation	5
Phenotype and disease course differences in monogenic and sporadic childhood lupus	5
Prenatal predisposing factors associated with neonatal lupus erythematosus	5
Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort	5
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	5
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	5
Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature	5
Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established	5
Chorea associated with systemic lupus erythematosus- a systematic review	5
Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report	5
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	5
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	5
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	5
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus	5
Should asymptomatic bacteriuria be treated in lupus nephritis?	5
Diffuse alveolar haemorrhage in systemic lupus erythematosus: A multicentre retrospective study in Singapore	5
CAR-modified cells and the sisyphus myth: A new panacea for lupus?	5
Laryngeal and voice dysfunction in systemic lupus erythematosus patients – A case-control study	5
Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus	5
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	4
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro	4
Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and dise	4
U-KIM-1 as a predictor of treatment response in lupus nephritis	4
Telitacicept for refractory cystitis associated with severe systemic lupus erythematosus: A case report	4
Importance of temporality and context in relation to life habit restrictions among patients with systemic lupus erythematosus: A psychosocial qualitative study	4
Belimumab safety in adult and paediatric Chinese patients with systemic lupus erythematosus: A Phase 4, multicentre, observational study	4
The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV)	4
Correlation between ABO blood group and clinical characteristics of patients with lupus nephritis	4
Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus	4
Serum pentraxin 3 in systemic lupus erythematosus: A potential indicator of cutaneous disease activity	4
Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study	4
Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice	4
Interferon signatures in systemic lupus erythematosus patients across ethnic groups	4
Factors affecting sleep quality in patients with systemic lupus erythematosus	4
Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis	4
Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study	4
COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series	4
Lupus band test for diagnostic evaluation in systemic lupus erythematosus	4
Retrobulbar blood flow velocity in systemic lupus erythematosus assessed by color Doppler imaging	4
Bibliometric analysis of childhood-onset systemic lupus erythematosus from 2000 to 2022	4
Machine learning: Predicting hospital length of stay in patients admitted for lupus flares	4
Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab	4
CCL21 and IP10 as serum biomarkers for pulmonary involvement in systemic lupus erythematosus	4
Plasma interleukin-22 level, variants in interleukin-22 gene polymorphism, and the severity of systemic lupus erythematosus among Egyptian pediatric and adolescents	4
Clinical and laboratory differences in pediatric-onset versus adult-onset lupus nephritis: A retrospective cohort analysis	4
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome regis	4
Treatment patterns in patients with systemic lupus erythematosus in New Zealand	4
Neutrophilic dermatoses as a manifestation of a systemic lupus erythematosus flare	4
Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets	4
Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review	4
Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes	4
Hypertension is associated with global and renal damage accrual in patients with systemic lupus erythematosus. Data from the Almenara Lupus Cohort	4
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus	4
Two-year treatment experience with BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: An exploratory, phase II maintenance trial	4
Mrs Denzil Fletcher	4
Unilateral lupus mastitis	4
Differential impact of disease activity and damage on health-related quality of life in patients with systemic lupus erythematosus	4
A murine Skint6 W168X allele contributes to autoimmune disease in a transgenic model	4
Subclinical systolic dysfunction by speckle tracking echocardiography in patients with systemic lupus erythematosus	4
Using combination of albumin to fibrinogen ratio and prognostic nutritional index model for predicting disease activity in patients with systemic lupus erythematosus	4
Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection	4
Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event	4
A review of the development of gangrene in patients with systemic lupus erythematosus – A 44-year follow-up study	4
Telehealth-supervised exercise in systemic lupus erythematosus: A pilot study	3
Uncommon toxic epidermal necrolysis -like presentation of cutaneous lupus erythematosus: A series of 6 cases	3
Dr. Eng Meng Tan August 26, 1926 - March 9, 2024 La Jolla, California	3
Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study	3